Stitch Fix Stock is Suddenly Hot. Here's Why.
Shares of the personalized styling service have jumped 40% in just a few weeks on little news.
Does an Apple Search Engine Make Sense?
The Mac maker is reportedly developing search technology as regulators scrutinize its deal with Google.
Pinterest's Earnings Demolish Expectations; Stock Soars 31%
Investors in the image-sharing platform operator seem poised to get a super Halloween treat a bit early.
Here's Why Walker & Dunlop Stock Soared on Thursday
The company gave investors some excellent results -- here's what they were.
Why Apple Stock Fell in After-Hours Trading Today
A sharp decline in iPhone sales and a lack of forward guidance sent some investors scurrying for the exits.
Is BioNTech Stock Really Headed to $119?
One bank in the company's native Germany believes the stock has a rich upside potential of 40%.
Here's Why Abiomed Dropped Today
Revenue bounces back, but growth is still lacking.
Why Moderna Stock Jumped Today
As COVID-19 cases mount, investors eagerly await the biotech's vaccine study results.
Why Curaleaf Holdings Smoked the Market on Thursday
Investors were happy about the expansion of a popular product line.
Stock Market Wrap-Up: Netflix Hikes Prices; Apple Reverses Lower After Earnings Report
Major market benchmarks were higher to recover some of their losses from earlier in the week.
Teladoc and Livongo Health Shareholders Approve the Companies' Merger
In both cases, over 99% of participants voted thumbs-up for the deal.
Why Criteo Jumped More Than 20% Today
The company's third-quarter earnings report prompted several analyst upgrades after management had tempered expectations in the second quarter.
Why Netflix Stock Popped 6% Today
A price hike for Netflix customers delivers a price pop to Netflix investors.
Nano-X Imaging Signs Deal With Ambra Health
Ambra Health's cloud solution will make it easier for medical professionals around the world to access the X-ray images taken by the new Nano-X device.
Shares of New Fortress Sink After Earnings
The niche power provider's third-quarter results weren't enough to keep Wall Street sticking around
ExxonMobil to Trim U.S. Workforce, Citing Cost Reductions and COVID-19
It's part of a broader cost-cutting effort by the top oil company.
Have Netflix? Get Ready to Pay More...
...unless you're subscribing to the cheapest of three available options. Otherwise, the digital video service's monthly prices just went up by a buck or two, according to a report.
Regeneron's Immunotherapy Is Given Priority Review for Treatment of New Lung Cancer Patients
The FDA has accepted an application that could expand Libtayo's addressable patient population to include an important niche.
Why Novavax Shares Vaulted Higher Today
It's a little complicated.
Nasdaq's Big Bounce Leaves These 2 Stay-at-Home Stocks Behind
The market rebounded from Wednesday's big losses in anticipation of a big slate of earnings.
EU Regulator Grants Label Expansion for GlaxoSmithKline's Ovarian Cancer Therapy
The European Commission has joined the Food and Drug Administration in accepting Zejula as a front-line therapy.
3 Hopeful Things to Say About Royal Caribbean's Ugly Quarter
The country's second largest cruise line reports a huge loss on negative revenue, but there are silver linings on the horizon.
GDP Grows at Record 33.1% in Q3, but Questions Remain About a Coronavirus Rebound.
The number represents a return to normal, more than a gain.